Ronnie Morris is CEO at CHAMPIONS ONCOLOGY, INC. (CSBR). They have made 14 open-market trades across 1 company since 2013, most recently 2023-03-17.
CIK 0001504443
13 open-market purchases totalling $779K since 2013, against 1 sale. Across 13 scored buys the stock is up 72.2% at ninety days, and 65.2 points ahead of the S&P over the same stretch.
13 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| CSBR | 858,878 | $4.2M |
Shares reported on the most recent Form 4, priced at the 2023-03-21 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 54% | 92% | 100% |
| Avg Move | +1.1% | +14.2% | +72.2% |
| Alpha | +2.1% | +11.5% | +65.2% |
| Scored | 13 | 13 | 13 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CSBR | BUY | 2023-03-17 | 2023-03-21 | $4.04 | $100K | -2.0% | +25.4% | +47.6% |
| CSBR | SELL | 2020-03-24 | 2020-03-26 | $5.25 | $394 | +9.4% | +22.3% | +45.8% |
| CSBR | BUY | 2020-03-20 | 2020-03-24 | $4.75 | $356 | +19.5% | +45.3% | +61.6% |
| CSBR | BUY | 2018-12-19 | 2018-12-20 | $7.44 | $149K | +7.5% | +29.7% | +42.0% |
| CSBR | BUY | 2018-03-26 | 2018-03-28 | $3.60 | $16K | +5.1% | +26.1% | +104.1% |
| CSBR | BUY | 2018-03-22 | 2018-03-26 | $3.49 | $2K | +0.0% | +13.6% | +90.6% |
| CSBR | BUY | 2016-10-21 | 2016-10-24 | $1.66 | $50K | -4.6% | +17.9% | +127.3% |
| CSBR | BUY | 2016-10-19 | 2016-10-20 | $1.70 | $17K | -11.2% | +1.1% | +92.2% |
| CSBR | BUY | 2016-10-14 | 2016-10-17 | $1.66 | $17K | +0.6% | +2.4% | +113.6% |
| CSBR | BUY | 2016-10-13 | 2016-10-14 | $1.67 | $49K | -3.5% | +12.6% | +105.8% |
| CSBR | BUY | 2016-10-10 | 2016-10-11 | $1.66 | $16K | -4.1% | +2.9% | +100.0% |
| CSBR | BUY | 2016-09-20 | 2016-09-21 | $1.58 | $5K | +0.4% | -2.0% | +44.2% |
| CSBR | BUY | 2014-03-19 | 2014-03-21 | $1.07 | $107K | +3.1% | +5.0% | +5.0% |
| CSBR | BUY | 2013-01-28 | 2013-01-30 | $0.50 | $250K | +3.1% | +5.0% | +5.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.